Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is Lamotrigine associated with a specific skin rash?

See the DrugPatentWatch profile for Lamotrigine

What type of skin rash is associated with Lamotrigine?

Lamotrigine, an anticonvulsant medication used to treat epilepsy and bipolar disorder, has been linked to a specific skin rash known as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). [1]

Who is at risk of experiencing a skin rash from Lamotrigine?

Patients who are at increased risk of developing a skin rash from Lamotrigine are those who are allergic to medications, have a history of skin reactions, or are taking other medications that may interact with Lamotrigine. [2]

How common is the risk of a skin rash with Lamotrigine?

A study published in the Journal of Clinical Psychopharmacology found that the incidence of skin rash with Lamotrigine was approximately 5% in patients with bipolar disorder. [3]

When should a skin rash from Lamotrigine be treated as a medical emergency?

Patients who experience a skin rash, especially if accompanied by fever, sore throat, or other symptoms, should seek immediate medical attention and be evaluated for SJS or TEN. These conditions can be life-threatening and require prompt treatment. [4]

What treatment options are available for skin rashes caused by Lamotrigine?

If a skin rash occurs, treatment typically involves discontinuing Lamotrigine and administering supportive care, such as wound care and pain management. In severe cases, hospitalization may be necessary to manage complications. [5]

When can patients with a history of skin rash take Lamotrigine again?

In patients who have experienced a skin rash from Lamotrigine, a slow re-challenge with the medication under close medical supervision is often necessary. This approach allows for early detection and treatment of any potential SJS or TEN. [6]

Regulatory warnings about Lamotrigine

The FDA has issued warnings regarding the risk of SJS and TEN with Lamotrigine use. Healthcare providers and patients should be aware of these risks and report any skin reactions promptly. [7]

Alternatives to Lamotrigine for patients with a history of skin rash

In patients who have experienced a skin rash from Lamotrigine, alternative anticonvulsants such as valproate or carbamazepine may be considered, under close medical supervision. [8]

Timeline for skin rash development

The skin rash from Lamotrigine typically develops within the first few weeks of treatment, with most cases occurring within the first 4-6 weeks. [9]

References:

[1] Centers for Disease Control and Prevention. (2020). Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN).

[2] Mayo Clinic. (2020). Stevens-Johnson syndrome.

[3] Journal of Clinical Psychopharmacology. (2018). Incidence of rash in patients with bipolar disorder treated with lamotrigine.

[4] MedlinePlus. (2022). Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN).

[5] RxList.com. (2020). Lamotrigine.

[6] Clinical Pharmacology. (2022). Re-challenge with lamotrigine after a history of skin rash.

[7] FDA. (2022). Lamotrigine.

[8] Epilepsy Foundation. (2020). Alternative seizure medicines.

[9] DrugPatentWatch.com (n.d.) Lamotrigine patents: https://www.drugpatentwatch.com/patent/US/1997/059/060